Assessment of Depression and Anxiety in Trichodynia Patients of Telogen Effluvium and Alopecia Areata

    January 2016 in “ International Journal of Medical Research and Health Sciences ”
    Atishay Bukharia, Nidhi Jain
    Image of study
    TLDR People with hair loss conditions like Telogen Effluvium and Alopecia Areata often feel scalp pain and are more likely to have anxiety, but not necessarily depression.
    In 2016, a study was conducted on 300 subjects, including 100 cases each of Telogen Effluvium, Alopecia Areata, and a control group, to assess the prevalence of Trichodynia (discomfort or pain of the scalp related to hair loss) and its association with anxiety and depression. The study found that Trichodynia was significantly more common in patients with Telogen Effluvium and Alopecia Areata compared to the control group, and was particularly higher in the Telogen Effluvium group. Anxiety was significantly higher in patients with Telogen Effluvium and Alopecia Areata who also had Trichodynia, compared to those without Trichodynia. However, there was no statistically significant difference found in terms of depression. The study concluded that Trichodynia is a common problem in patients with Telogen Effluvium and Alopecia Areata, and is frequently associated with anxiety.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 420 results

      community any news about DUPA (Diffuse unpatterned alopecia)?

      in Research/Science  9 upvotes 2 years ago
      The conversation discusses diffuse unpatterned alopecia (DUPA) and its possible causes, including sensitivity to DHT, not being androgenic alopecia, being diffuse alopecia areata, or hormonal issues. Treatments mentioned include topical melatonin, Clobetasol Propionate for alopecia areata, and the lack of results from using finasteride, dutasteride, and minoxidil.

      community No idea what's causing my hair thinning

      in Chat  2 upvotes 2 months ago
      The user is experiencing diffuse hair thinning despite using finasteride and oral minoxidil, with no hairline recession or bald spots. Suggestions include checking for telogen effluvium, considering a JAK inhibitor for potential autoimmune issues, and conducting further tests to rule out other causes.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

    Related Research

    6 / 6 results